nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0655	0.0655	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0574	0.0574	CbGpPWpGaD
Flunitrazepam—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0517	0.0517	CbGpPWpGaD
Flunitrazepam—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0454	0.0454	CbGpPWpGaD
Flunitrazepam—UGT1A3—Phase II conjugation—CNDP2—pharynx cancer	0.0348	0.0348	CbGpPWpGaD
Flunitrazepam—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0311	0.0311	CbGpPWpGaD
Flunitrazepam—UGT2B7—Phase II conjugation—CNDP2—pharynx cancer	0.0296	0.0296	CbGpPWpGaD
Flunitrazepam—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0273	0.0273	CbGpPWpGaD
Flunitrazepam—UGT1A1—Phase II conjugation—CNDP2—pharynx cancer	0.024	0.024	CbGpPWpGaD
Flunitrazepam—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.024	0.024	CbGpPWpGaD
Flunitrazepam—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.021	0.021	CbGpPWpGaD
Flunitrazepam—UGT1A3—NRF2 pathway—ADH7—pharynx cancer	0.021	0.021	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—CNDP2—pharynx cancer	0.0203	0.0203	CbGpPWpGaD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0184	0.0184	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—ADH7—pharynx cancer	0.0184	0.0184	CbGpPWpGaD
Flunitrazepam—UGT2B7—NRF2 pathway—ADH7—pharynx cancer	0.0178	0.0178	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—CNDP2—pharynx cancer	0.0173	0.0173	CbGpPWpGaD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0162	0.0162	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—ADH1B—pharynx cancer	0.0161	0.0161	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—ADH7—pharynx cancer	0.0156	0.0156	CbGpPWpGaD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0149	0.0149	CbGpPWpGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0146	0.0146	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—ADH7—pharynx cancer	0.0145	0.0145	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—CNDP2—pharynx cancer	0.014	0.014	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—ADH1B—pharynx cancer	0.0137	0.0137	CbGpPWpGaD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.013	0.013	CbGpPWpGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0128	0.0128	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—ADH7—pharynx cancer	0.0127	0.0127	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0112	0.0112	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.0112	0.0112	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—ADH1B—pharynx cancer	0.0111	0.0111	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.0108	0.0108	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0102	0.0102	CbGpPWpGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00986	0.00986	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.00979	0.00979	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00899	0.00899	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00879	0.00879	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00876	0.00876	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00874	0.00874	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.00859	0.00859	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	0.00856	0.00856	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.0079	0.0079	CbGpPWpGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.0079	0.0079	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—ADH7—pharynx cancer	0.00774	0.00774	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00768	0.00768	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00693	0.00693	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	0.00679	0.00679	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00676	0.00676	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.0066	0.0066	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00602	0.00602	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00597	0.00597	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00593	0.00593	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00546	0.00546	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00544	0.00544	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00524	0.00524	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00514	0.00514	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00477	0.00477	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00465	0.00465	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00461	0.00461	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00408	0.00408	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00397	0.00397	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00359	0.00359	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CNDP2—pharynx cancer	0.00348	0.00348	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00315	0.00315	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ADH7—pharynx cancer	0.00314	0.00314	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CNDP2—pharynx cancer	0.00296	0.00296	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ADH1B—pharynx cancer	0.00276	0.00276	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ADH7—pharynx cancer	0.00267	0.00267	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—B4GALT5—pharynx cancer	0.00264	0.00264	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CNDP2—pharynx cancer	0.0024	0.0024	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ADH1B—pharynx cancer	0.00234	0.00234	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—B4GALT5—pharynx cancer	0.00224	0.00224	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ADH7—pharynx cancer	0.00217	0.00217	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.002	0.002	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.002	0.002	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ADH1B—pharynx cancer	0.00191	0.00191	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.00185	0.00185	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—B4GALT5—pharynx cancer	0.00182	0.00182	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ADH7—pharynx cancer	0.00167	0.00167	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.00149	0.00149	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.00147	0.00147	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CNDP2—pharynx cancer	0.00146	0.00146	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.0014	0.0014	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ADH7—pharynx cancer	0.00135	0.00135	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ADH7—pharynx cancer	0.00132	0.00132	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.00118	0.00118	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ADH1B—pharynx cancer	0.00116	0.00116	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.00113	0.00113	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.00113	0.00113	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—B4GALT5—pharynx cancer	0.00111	0.00111	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.00103	0.00103	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADH7—pharynx cancer	0.00102	0.00102	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000931	0.000931	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000895	0.000895	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.00088	0.00088	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000856	0.000856	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000816	0.000816	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000796	0.000796	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.00078	0.00078	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000698	0.000698	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000679	0.000679	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000667	0.000667	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000614	0.000614	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000538	0.000538	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000515	0.000515	CbGpPWpGaD
